Diversifying Diagnostics to Make a Difference.

In this episode, Nathan speaks with Richard Acton, former CSO at Cignpost Diagnostics, about transitioning a company from a COVID testing business to a health and wellness business.

Cignpost Diagnostics is a leading health and diagnostics company, operating globally to empower and guide people towards living a healthier life. By combining scientific expertise with a relentless focus on people, Cignpost has quickly evolved to become a global leader in COVID-19 screening and health diagnostics, establishing safe, managed environments across a range of sectors, including elite sports, defence, film and TV production, and financial services.

Richard has an extensive history growing and accelerating businesses in the point-of-care market, working on R&D, lab operations, quality and clinical functions and plenty more. With experience gaining certification in the space and working to lead scientific operations for a COVID testing company throughout the pandemic sees Richard share exciting insight and knowledge from his time at Cignpost.

If you are interesting in learning about all things POC from the perspective of a company at the forefront of innovation who is well versed in diversification and overcoming challenges to create success, then be sure to have a listen.

If you'd like to chat some more about the themes in this episode, are keen to feature on a podcast yourself or want to learn more about CM Life Science's services; then please get in touch at nathan.sharpe@lifesci-cm.com or let's connect on LinkedIn.

Hosted on Acast. See acast.com/privacy for more information.